20Apr 2025
Diabetic Patients Show Poorer Anatomical Response to Anti-VEGF in nAMD Treatment

Diabetic Patients Show Poorer Anatomical Response to Anti-VEGF in nAMD Treatment

In a study of over 1,000 eyes treated for neovascular age-related macular degeneration (nAMD), diabetic patients—especially those with moderate diabetic retinopathy—showed a significantly higher persistence of subretinal fluid (SRF) after anti-VEGF therapy. While visual and retinal thickness outcomes improved in all patients, diabetes appears to hinder full anatomical response.

  • #ophthalmology

Like

Save

Share